JPMorgan Trust II has filed its latest financial report, revealing significant details about its asset management strategies. The NPORT-P filing, submitted on October 28, 2026, highlights the fund's total assets, liabilities, and net assets, providing insight into its financial health and operational performance.
As of August 31, 2026, the fund reported total assets amounting to approximately $811.8 million, with total liabilities of $1.6 million, resulting in net assets of about $810.2 million. This filing is crucial as it reflects the fund's management capabilities and its positioning within the competitive landscape of the investment industry.
Background
JPMorgan Trust II, identified under the Central Index Key (CIK) 0000763852, operates as an investment entity. The company is incorporated in Delaware and has a business address at 390 Madison Avenue, New York, NY. The filing history shows that it is actively engaged in reporting its financial status, with multiple NPORT-P filings submitted on the same date.
What the Filing Says
The NPORT-P filing indicates that the fund's total assets stood at $811,844,561.06, while total liabilities were reported at $1,626,626.51. The net assets, therefore, were calculated to be $810,217,934.55. The report also includes various metrics related to interest rate risk and credit spreads, which are critical for assessing the fund's investment strategy and risk management.
Impact
This financial update may affect various stakeholders, including investors, analysts, and competitors in the investment sector. The reported figures can influence investor confidence and market perceptions of JPMorgan Trust II's management effectiveness. Additionally, competitors will be keen to analyze these results to gauge their relative performance and market positioning.
What's Next
The filing does not specify what happens next, leaving stakeholders to anticipate further updates or actions from JPMorgan Trust II in response to these financial disclosures.
Read Next
CEO Mark Jeffery Reports Significant Stock Transactions
Moritz Robert Edward Jr. acquires shares of Northern Trust
Medpace Holdings' General Counsel Sells 1,245 Shares
Cytokinetics CEO Robert I. Blum Executes Stock Transactions
Etsy's Josh Silverman Sells 41,500 Shares in Recent Filing
Director Henry B. Smith sells 4,893 shares of Axis Capital







